期刊文献+

食管癌及癌前病变中NF-κB p65/p50蛋白的表达 被引量:17

NF-κBp65/p50 protein expression in esophageal cancer and precancerous lesions at high incidence area in Henan
下载PDF
导出
摘要 目的探讨核转录因子NF-κB p65/p50蛋白在食管癌与癌前病变组织的变化特征及其生物学意义。方法采用免疫组化ABC法检测食管癌手术标本的NF-κB p65/p50蛋白表达状况并分析其特征。结果NF-κB p65/p50在正常食管鳞状上皮组织无表达,而在基底细胞增生(38%/32%)、间变(54%/46%)、原位癌(53%/47%)和鳞状细胞癌(69%/62%)均出现不同程度的阳性表达,并随病变进展,阳性表达率明显升高。而基底细胞增生与鳞癌之间表达率差异有显著性(P<0·05)。NF-κB p65/p50在食管鳞癌中表达有异质性。结论NF-κB p65/p50蛋白表达变化是食管癌和癌前病变组织常见的分子事件,可能在食管鳞癌癌变过程中起一定作用。 Purpose To evaluate the significance of NF-κB p65/p50 expression in esophageal cancer and precancerous lesions. Methods Immunohistochemistry (ABC) method was undertaken to determine the expression of NF-κB p65 and p50 proteins in esophageal carcinogenesis. Results The NF-κB p65 and p50 expression were not observed in normal esophageal epithelium, However, the different severity of NF-κB p65/p50 expression was observed in based cell hyperplasia (BCH, 38%/32% ) , dysplasia (54%/46%) , carcinoma in situ (53%/47%) and squamous cell carcinoma (SCC, 69%/62% ). The positive rates for NF-κB p65 and p50 proteins increased with the lesion progression. Moreover, there were significant relationships among BCH, and dysplasia and SCC (P 〈 0. 05), The heterogeneity of NF-κB p65 and p50 expression in esophageal squamous carcinoma was observed. Conclusions NF-κB p65 and p50 proteins are frequent molecular events in esophageal precancerous and cancerous lesions and may play an important role in esophageal carcinogenesis.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2006年第5期560-562,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 国家杰出青年科学基金(No30025016) 河南省高校创新人才工程基金(No1999125) 河南省医药卫生创新人才工程基金(No200084) 河南省食管癌重点开放实验室基金(No20050227) 郑州大学211工程项目
关键词 食管肿瘤 鳞状细胞 NF—KB 癌前状态 esophageal neoplasms carcinoma, squamous cell NF kappa B percancerous conditions
  • 相关文献

参考文献8

  • 1Perkins N D. NF-kappa B: tumor promoter or suppressor [ J ] ? Trends Cell Biol, 2004,14(2) :64 -69.
  • 2黄培林,朱世能,陆世伦.NF-κB、IκB与肿瘤细胞凋亡[J].实用癌症杂志,2001,16(1):103-104. 被引量:5
  • 3Wang L D, Hong J Y, Qiu S L, et al. Accumulation of p53 protein in human esophageal precaneerous lesions: a possible early biomarker for carcinogenesis [ J ]. Caneer Res, 1993, 53 ( 8 ) :1783 - 1787.
  • 4Jian Li,Chang Wei Feng,Zhi Guo Zhao,Qi Zhou,Li Dong Wang.A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions[J].World Journal of Gastroenterology,2000,6(2):278-280. 被引量:15
  • 5Nakayama H, lkebe T, Beppu M, et al. High expression levels of nuclear factor kappa B,I kappa B kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity [ J ]. Cancer,2001,92(12) : 3037 -3044.
  • 6Yamanaka N, Sasaki N, Tasaki A,et al. Nuclear factor-kappa B p65 is a prognostic indicator in gastric carcinoma[J ]. Anticancer Res, 2004, 24(2C) : 1071 -1075.
  • 7Abdel-Latif M M, O'Riordan J, Windle H J ,et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy[J]. Ann Surg, 2004, 239(4): 491 -495.
  • 8Rodriguez A C, Ingelman S M. Cytochrome p450 pharmacogenetics and cancer [ J ]. Oncogene, 2006,25 ( 11 ) : 1679 - 1691.

二级参考文献16

  • 1Wang LD,Lipkin M,Qiu ML,Yang GR,Yang CS,Newmark HL.Labdling index and labelling distribution of cells in esophageal epithdium of individual at increased risk for esophageal cancer in Huixian,China. Cancer Research . 1990
  • 2Li J,Niu ZX,Wang LD.Study on molecular biology of esophageal carcinoma. Xin Xiaohuabingxue Zazhi . 1997
  • 3Wang LD.The molecular biology of esophageal cancer. Development of molecular pathology in esophageal carcinoma . 1994
  • 4Wang L D,Hong J Y,Qiu S L,et al.Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Research . 1993
  • 5BosJL,etal.ras oncogenes in human cancer: a review. Cancer Research . 1989
  • 6Wang LD,Shi ST,Zhou Q,Goldstein S,Hong JY,Shao P,Qiu SL,Yang CS.Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. International Journal of Cancer . 1994
  • 7Wang LD,Zhou Q,Hong JY,et al.P53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in henan. China Cancer . 1996
  • 8Stemmermann,G,Heffelfinger,SC,Noffsinger,A,Hui,YZ,Miller,MA,Fenoglio-Preiser,CM.The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Human Pathology . 1994
  • 9Hollstein,MC,Peri,L,Mandard,AM,Welsh,JA,Montesano,R,Metcalf,RA,Bak,M,Harriss,CC.Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence ofras mutations. Cancer Research . 1991
  • 10Jiang W,Kahn SM,Guillem JG,Lu SH,Weinstein IB.Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncegene . 1989

共引文献18

同被引文献126

引证文献17

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部